These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3876164)

  • 21. Fluxes and distribution of calcium in rat liver cells: kinetic analysis and identification of pools.
    Claret-Berthon B; Claret M; Mazet JL
    J Physiol; 1977 Nov; 272(3):529-52. PubMed ID: 412957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human alpha lymphotoxin (LT): studies examining the mechanism(s) of LT-induced inflammation and tumor destruction in vivo.
    Jeffes EW; Averbook BJ; Ulich TR; Granger GA
    Lymphokine Res; 1987; 6(2):141-9. PubMed ID: 3495706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphotoxin amplification of tumor growth inhibition is specific for natural killer cells but not for macrophages.
    Ransom JH; Pintus C; Evans CH
    Int J Cancer; 1983 Jul; 32(1):93-7. PubMed ID: 6602781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the mechanism of action of guinea pig lymphotoxin. I. Membrane active substances prevent target cell lysis by lymphotoxin.
    Okamoto M; Mayer MM
    J Immunol; 1978 Jan; 120(1):272-8. PubMed ID: 304869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of lymphocyte-mediated cytotoxicity. III. Characterization of the mechanism of inhibition of the human alloimmune lymphocyte-mediated cytotoxic reaction by polyspecific anti-lymphotoxin sera in vitro.
    Ware CF; Granger GA
    J Immunol; 1981 May; 126(5):1934-40. PubMed ID: 6971314
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of phospholipase activation in cell killing.
    Ciba Found Symp; 1987; 131():83-7. PubMed ID: 3502461
    [No Abstract]   [Full Text] [Related]  

  • 27. In vitro synergism between interferons and human lymphotoxin: enhancement of lymphotoxin-induced target cell killing.
    Williams TW; Bellanti JA
    J Immunol; 1983 Feb; 130(2):518-20. PubMed ID: 6600238
    [No Abstract]   [Full Text] [Related]  

  • 28. Mechanisms of lymphocyte-mediated cytotoxicity. I. The effects of anti-human lymphotoxin antisera on the cytolysis of allogeneic B cell lines by MLC-sensitized human lymphocytes in vitro.
    Ware CF; Granger GA
    J Immunol; 1981 May; 126(5):1919-26. PubMed ID: 6452481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of lymphotoxin on target-cell plasma-membrane lipids.
    Rosenau W; Burke GC; Anderson R
    Cell Immunol; 1981 May; 60(1):144-54. PubMed ID: 6972262
    [No Abstract]   [Full Text] [Related]  

  • 30. [Increase of the L-cell sensitivity to lymphotoxin].
    Reizenbuk VG; Sarv IR
    Lab Delo; 1980; (4):238-40. PubMed ID: 6155554
    [No Abstract]   [Full Text] [Related]  

  • 31. Leukoregulin, a direct-acting anticancer immunological hormone that is distinct from lymphotoxin and interferon.
    Ransom JH; Evans CH; McCabe RP; Pomato N; Heinbaugh JA; Chin M; Hanna MG
    Cancer Res; 1985 Feb; 45(2):851-62. PubMed ID: 3881174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphotoxin. A review and analysis.
    Rosenau W; Tsoukas CD
    Am J Pathol; 1976 Sep; 84(3):580-96. PubMed ID: 786035
    [No Abstract]   [Full Text] [Related]  

  • 33. The LT system in experimental animals. IV. Rapid specific lysis of 51CR-labeled allogeneic target cells by highly unstable high m.w. lymphotoxin-receptor complex(es) released in vitro by activated alloimmune murine T lymphocytes.
    Hiserodt JC; Tiangco GJ; Granger GA
    J Immunol; 1979 Jul; 123(1):332-41. PubMed ID: 312879
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of human lymphocyte-mediated mitogen-induced cytotoxicity of murine L-929 cells by heterologous anti-human lymphotoxin antisera in vitro.
    Hiserodt JC; Granger GA
    J Immunol; 1977 Aug; 119(2):374-80. PubMed ID: 301888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alteratons in RNA synthesis in lymphotoxin-treated target cells.
    Kunitomi G; Rosenau W; Burke GC; Goldberg ML
    Am J Pathol; 1975 Aug; 80(2):249-60. PubMed ID: 1080634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphotoxin, a biologically relevant model lymphokine.
    Ruddle NH; Powell MB; Conta BS
    Lymphokine Res; 1983; 2(1):23-31. PubMed ID: 6206361
    [No Abstract]   [Full Text] [Related]  

  • 37. Spontaneous cytotoxicity (SCMC) of normal human lymphocytes against a human melanoma cell line: a phenomenon due to a lymphotoxin-like mediator.
    Peter HH; Eife RF; Kalden JR
    J Immunol; 1976 Feb; 116(2):342-8. PubMed ID: 1082453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA fragmentation: manifestation of target cell destruction mediated by cytotoxic T-cell lines, lymphotoxin-secreting helper T-cell clones, and cell-free lymphotoxin-containing supernatant.
    Schmid DS; Tite JP; Ruddle NH
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1881-5. PubMed ID: 2937063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphotoxin enhances the susceptibility of neoplastic and preneoplastic cells to natural killer cell mediated destruction.
    Ransom JH; Evans CH
    Int J Cancer; 1982 Apr; 29(4):451-8. PubMed ID: 6979521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro expression of factor-mediated cytotoxic activity generated during the immune response to Chlamydia in the mouse.
    Byrne GI; Krueger DA
    J Immunol; 1985 Jun; 134(6):4189-93. PubMed ID: 3872911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.